Wednesday, March 18, 2015 12:05:00 PM
I am waiting eagerly for the presentation!
I think the interim clinical data - phase IIb KOA - will be very good. They won´t presentate bad results on the 2015 Annual Regen Med Invenstor Day!
I am also very excited about the CAR-T cell programs! A lot of investors will realise that CBMG has this technologie (third generation) ... and also the next big market (China).
Good weeks, months, years are ahead!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM